Jason LaBonte

Jason was a California native until he abandoned the sunshine and traveled east. He attended Princeton University in New Jersey, receiving his A.B. in molecular biology in 1997. His thesis work with Dr. Thomas Shenk used adeno-associated virus vectors to create mutations in human cytomegolovirus. Jason received his Ph.D. from Harvard University working in the lab of Dr. Joseph Sodroski. His graduate thesis used HIV viral vectors to explore the role of HIV-1 envelope glycoproteins in viral pathogenesis, as well as to identify novel animal models for HIV research. Jason currently works for Decision Resources, Inc. as a business and market analyst for the pharmaceutical and biotech industry. He enjoys spending his free time with his wife Michelle, daughter Emily, and small dog Peanut.

Kim Seth

During graduate school, Kim was the founding CEO and President of Xpogen, Inc., a venture-backed bioinformatics company located in Cambridge, MA. Following Xpogen, Kim worked in business development at Epix Pharmaceuticals, where he focused on M&A and licensing activities, including the transformative ~$130M acquisition of Predix Pharmaceuticals in 2006. He then moved to Goldman Sachs & Co. where, as Vice President in healthcare equity research, his focus has included Pharmaceuticals, Specialty Pharmaceuticals, Diagnostics and Lifescience Tools sectors.

Kim received his PhD in Neurobiology from Harvard Medical School. His thesis work focused on the molecular genetics and mechanisms of transcriptional regulation of the gene for corticotropin- releasing hormone (CRH), which plays a critical role in initiating the stress response and has been implicated in such conditions as depression, anorexia nervosa, and drug/alcohol addiction.

Prior to graduate school, Kim received his BA cum laude in Economics from Harvard College and worked in management consulting at CSC/Index and the Parthenon Group.

Peter Kolchinsky

Peter Kolchinsky is a co-founder and General Partner of RA Capital Management, which has been investing in healthcare companies since 2002. He is a member of the National Academies Board on Global Science and Technology, authored an e-book titled “The Entrepreneur’s Guide to a Biotech Startup”, and serves as an advisor to startup companies and non-profits. Peter received his undergraduate degree in Biology from Cornell University and a Ph.D. in Virology from Harvard University, where he conducted research at Dana-Farber Cancer Institute on the entry mechanism of Human Immunodeficiency Virus (HIV).